| Clinical risk factors associated with radiographic osteoarthritis progression among people with knee pain: a longitudinal study 2021 · glucosamine sulfate and chondroitin sulfate (double active) · Adults aged 45–75 with symptomatic knee osteoarthritis | 800 mg | 1.5 g | 2 years | — |
| Combined glucosamine and chondroitin sulfate, once or three times daily, provides clinically relevant analgesia in knee osteoarthritis 2015 · GIII · Adults with radiographic knee osteoarthritis, Kellgren/Lawrence grade 2–3; age and sex not specified | 1.2 g | 1.5 g | 16 weeks | 306 |
| Combined glucosamine and chondroitin sulfate, once or three times daily, provides clinically relevant analgesia in knee osteoarthritis 2015 · GI · Adults with radiographic knee osteoarthritis, Kellgren/Lawrence grade 2–3; age and sex not specified | 1.2 g | 1.5 g | 16 weeks | 302 |
| Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study 2016 · GC group · Men and women aged 40–75 with moderate-to-severe knee osteoarthritis | 1.2 g | 1.5 g | 180 days | 66 |
| Effectiveness of Cucumis sativus extract versus glucosamine-chondroitin in the management of moderate osteoarthritis: a randomized controlled trial 2018 · GC Group · Males and females aged 40–75 years with mild to moderate knee osteoarthritis | 600 mg | 750 mg | 180 days | 61 |
| Effects of N-acetyl glucosamine and chondroitin sulfate supplementation on knee pain and self-reported knee function in middle-aged and older Japanese adults: a randomized, double-blind, placebo-controlled trial 2016 · Glu/Cho group · Japanese adults aged 52–87 with knee pain and/or stiffness | 180 mg | 100 mg | 24 weeks | 50 |
| Comparison of Glucosamine-Chondroitin Sulfate with and without Methylsulfonylmethane in Grade I-II Knee Osteoarthritis: A Double Blind Randomized Controlled Trial 2017 · GCM · Patients with Kellgren-Lawrence grade I-II knee osteoarthritis; age and sex not specified | 1.2 g | 1.5 g | 90 days | 50 |
| Comparison of Glucosamine-Chondroitin Sulfate with and without Methylsulfonylmethane in Grade I-II Knee Osteoarthritis: A Double Blind Randomized Controlled Trial 2017 · GC · Patients with Kellgren-Lawrence grade I-II knee osteoarthritis; age and sex not specified | 1.2 g | 1.5 g | 90 days | 49 |
| Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial 2009 · Glucosamine HCl plus chondroitin sulfate group (G+C) · Adults with moderate to severe osteoarthritis of the knee; age and sex distribution not specified for this arm. | 600 mg | 750 mg | 90 days | 26 |
| The effect of oral low molecular weight liquid hyaluronic acid combination with glucosamine and chondroitin on knee osteoarthritis patients with mild knee pain: An 8-week randomized double-blind placebo-controlled trial 2021 · A+HA group · Men and women aged 40 years or older with knee osteoarthritis and mild knee pain | 250 mg | 750 mg | 8 weeks | 24 |
| A randomized double-blind clinical trial of the effect of chondroitin sulfate and glucosamine hydrochloride on temporomandibular joint disorders: a pilot study 2001 · active medication group · People diagnosed with capsulitis, disk displacement, disk dislocation, or painful osteoarthritis of the temporomandibular joint | 1.2 g | 1.5 g | 12 weeks | 14 |
| Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis 2000 · intervention group · Adults with knee osteoarthritis; age and sex not reported | 1.6 g | 2 g | 26 weeks | — |
| Potential effects of chondroitin sulfate on joint swelling: a GAIT report 2008 · glucosamine plus chondroitin sulfate · Adults with symptomatic, radiographic knee osteoarthritis | 1.2 g | 1.5 g | 24 weeks | — |
| Effect of a dietary supplement containing glucosamine hydrochloride, chondroitin sulfate and quercetin glycosides on symptomatic knee osteoarthritis: a randomized, double-blind, placebo-controlled study 2012 · GCQ supplement · Japanese subjects with symptomatic knee osteoarthritis | 60 mg | 1.2 g | 16 weeks | — |
| Curcumagalactomannoside/Glucosamine Combination Improved Joint Health Among Osteoarthritic Subjects as Compared to Chondroitin Sulfate/Glucosamine: Double-Blinded, Randomized Controlled Study 2020 · Group II (CHN-GLN) · Adults with confirmed class I–III osteoarthritis; ages not reported; 38 males and 42 females across both groups | 830 mg | 1 g | 12 weeks | — |
| Treatment of knee osteoarthritis with a new formulation of a fixed-dose combination of glucosamine sulfate and bovine chondroitin: a multicenter, randomized, single-blind, non-inferiority clinical trial 2021 · GS/CS group · Patients with knee osteoarthritis, Kellgren-Lawrence grades 2 or 3, with a mean WOMAC pain subscale score of at least 40 mm | 1.2 g | 1.5 g | 24 weeks | — |
| Glucosamine-containing supplement improves locomotor functions in subjects with knee pain: a randomized, double-blind, placebo-controlled study 2015 · GCQID group · Japanese women and men aged 40–74 years with knee pain | 60 mg | 1.2 g | 16 weeks | 50 |
| Effects of cartilage-supporting nutritional supplementation on knee osteoarthritis symptoms and quality of life in a 12-week randomized double-blind placebo-controlled pilot study 2025 · Verum · Adults with mild-to-moderate knee osteoarthritis and slight-to-moderate knee pain; mean age 62.7 years; women and men | 200 mg | — | 12 weeks | 36 |
| Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: a randomized, double-blind, placebo-controlled pilot study 1999 · combination therapy · male U.S. Navy diving and special warfare personnel with chronic pain and radiographic degenerative joint disease of the knee or low back | 1.2 g | 1.5 g | 16 weeks | — |
| Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens 2015 · glucosamine-chondroitin combination · Adults aged 45–75 with chronic knee pain and medial tibio-femoral compartment narrowing consistent with symptomatic knee osteoarthritis | 800 mg | 1.5 g | 2 years | 151 |
| Differences in Serum Biomarkers Between Combined Glucosamine and Chondroitin Versus Celecoxib in a Randomized, Double-blind Trial in Osteoarthritis Patients 2020 · Combined glucosamine hydrochloride plus chondroitin sulfate (GH+CS) · Patients with knee osteoarthritis; age and sex not specified | 1.2 g | 1.5 g | 26 weeks | 96 |
| Randomized trial of glucosamine and chondroitin supplementation on inflammation and oxidative stress biomarkers and plasma proteomics profiles in healthy humans 2015 · Glucosamine and chondroitin (G&C) intervention · Healthy, overweight, non-smoking men and women aged 20–55 years | 1.2 g | 1.5 g | 4 weeks | 18 |
| Effects of glucosamine-chondroitin combination on synovial fluid IL-1β, IL-6, TNF-α and PGE2 levels in internal derangements of temporomandibular joint 2015 · study group · Women aged 18–40 with internal derangement of the temporomandibular joint, pain lasting longer than 4 weeks, and limitation in mouth opening | 1.2 g | 1.5 g | 8 weeks | — |
| Influence of a low-dose supplementation of curcumagalactomannoside complex (CurQfen) in knee osteoarthritis: A randomized, open-labeled, active-controlled clinical trial 2021 · GLN-CHN combination group · Adults with knee osteoarthritis | 830 mg | 1 g | 6 weeks | — |